Variant report

Variant	nsv832641
Chromosome Location	chr13:67671691-67708713
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:27)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:27 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:67687472..67689479-chr13:67704392..67705946,2	K562	blood:
2	chr13:67673168..67676018-chr13:67680338..67682100,2	K562	blood:
3	chr13:67660306..67662402-chr13:67696166..67698306,2	K562	blood:
4	chr13:67686150..67689268-chr13:67693283..67697595,5	K562	blood:
5	chr13:67675315..67677350-chr13:67683836..67685961,2	K562	blood:
6	chr13:67686001..67691093-chr13:67707345..67712221,5	K562	blood:
7	chr13:67685964..67690654-chr13:67706296..67711657,6	K562	blood:
8	chr13:67702842..67705667-chr13:67707651..67711312,4	K562	blood:
9	chr13:67673168..67676018-chr13:67680338..67682100,2	K562	blood:
10	chr13:67681587..67685897-chr13:67688405..67692463,6	K562	blood:
11	chr13:67698083..67700641-chr13:67703157..67705033,2	K562	blood:
12	chr13:67695998..67698789-chr13:67699013..67700576,2	K562	blood:
13	chr13:67701562..67704458-chr13:67707651..67710683,4	K562	blood:
14	chr13:67681587..67685897-chr13:67688405..67692463,6	K562	blood:
15	chr13:67698083..67700641-chr13:67703157..67705033,2	K562	blood:
16	chr13:67674917..67677595-chr13:67687583..67689856,3	K562	blood:
17	chr13:67702842..67705667-chr13:67707651..67711312,4	K562	blood:
18	chr13:67686001..67691093-chr13:67707345..67712221,5	K562	blood:
19	chr13:67701562..67704458-chr13:67707651..67710683,4	K562	blood:
20	chr13:67686713..67688646-chr13:67690649..67692733,2	K562	blood:
21	chr13:67687472..67689479-chr13:67704392..67705946,2	K562	blood:
22	chr13:67686150..67689268-chr13:67693283..67697595,5	K562	blood:
23	chr13:67685964..67690654-chr13:67706296..67711657,6	K562	blood:
24	chr13:67674917..67677595-chr13:67687583..67689856,3	K562	blood:
25	chr13:67695998..67698789-chr13:67699013..67700576,2	K562	blood:
26	chr13:67686713..67688646-chr13:67690649..67692733,2	K562	blood:
27	chr13:67675315..67677350-chr13:67683836..67685961,2	K562	blood:

No data

Extended variants
information (count: 1272 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:1272 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565485994	chr13:67671694-67671695	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs534393642	chr13:67671714-67671715	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs558103857	chr13:67671743-67671744	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs114337271	chr13:67671772-67671773	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs543626622	chr13:67671878-67671879	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs571198792	chr13:67671885-67671886	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs150849857	chr13:67671888-67671889	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs139306954	chr13:67671954-67671955	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs547306250	chr13:67671990-67671991	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs187550696	chr13:67672074-67672075	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs73212710	chr13:67672132-67672133	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs535956775	chr13:67672180-67672181	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs376165240	chr13:67672207-67672208	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs571963220	chr13:67672271-67672272	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs374860365	chr13:67672273-67672274	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs78827687	chr13:67672403-67672404	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs545497607	chr13:67672419-67672420	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs9529184	chr13:67672506-67672507	Weak transcription Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs533151857	chr13:67672508-67672509	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs549667611	chr13:67672509-67672510	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs557793617	chr13:67672542-67672543	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs563286805	chr13:67672576-67672577	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs367605638	chr13:67672615-67672616	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs377190336	chr13:67672630-67672631	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs548598485	chr13:67672664-67672665	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs565323435	chr13:67672721-67672722	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs150024557	chr13:67672745-67672746	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs545510975	chr13:67672773-67672774	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs551476871	chr13:67672828-67672829	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs146610432	chr13:67672852-67672853	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs537661508	chr13:67672877-67672878	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs61959369	chr13:67672918-67672919	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs555139405	chr13:67673065-67673066	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs531368359	chr13:67673122-67673123	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs574414037	chr13:67673141-67673142	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs536928340	chr13:67673187-67673188	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs75826894	chr13:67673248-67673249	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs573294036	chr13:67673278-67673279	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs201137054	chr13:67673284-67673285	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs141398294	chr13:67673330-67673331	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs561681651	chr13:67673333-67673334	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs575643268	chr13:67673353-67673354	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs543651000	chr13:67673377-67673378	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs563123239	chr13:67673381-67673382	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs12876406	chr13:67673407-67673408	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs529187331	chr13:67673454-67673455	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs143878710	chr13:67673472-67673473	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs559195402	chr13:67673516-67673517	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs78489524	chr13:67673524-67673525	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs551050860	chr13:67673528-67673529	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Prostate cancer	16461572	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Schizophrenia	23813976	CNVD
Prostate cancer	22341455	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:466 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:67665800-67673000	Weak transcription	Brain Cingulate Gyrus	brain
2	chr13:67666200-67675000	Weak transcription	HSMMtube	muscle
3	chr13:67667800-67678600	Enhancers	Brain Substantia Nigra	brain
4	chr13:67669200-67676000	Weak transcription	Adipose Nuclei	Adipose
5	chr13:67669400-67674600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr13:67669800-67673800	Enhancers	Hela-S3	cervix
7	chr13:67670000-67671800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr13:67670200-67672000	Weak transcription	Brain Angular Gyrus	brain
9	chr13:67670800-67671800	Weak transcription	Brain Hippocampus Middle	brain
10	chr13:67670800-67672000	Weak transcription	Brain Anterior Caudate	brain
11	chr13:67670800-67677800	Weak transcription	K562	blood
12	chr13:67671000-67675000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
13	chr13:67671000-67676000	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
14	chr13:67671400-67672600	Enhancers	Brain Inferior Temporal Lobe	brain
15	chr13:67671600-67672000	Flanking Active TSS	A549	lung
16	chr13:67671800-67672400	Enhancers	Brain Hippocampus Middle	brain
17	chr13:67671800-67673000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr13:67672000-67672600	Enhancers	Brain Angular Gyrus	brain
19	chr13:67672000-67673400	Enhancers	Brain Anterior Caudate	brain
20	chr13:67672000-67677600	Active TSS	A549	lung
21	chr13:67672400-67673200	Weak transcription	Brain Hippocampus Middle	brain
22	chr13:67672600-67674600	Weak transcription	Brain Inferior Temporal Lobe	brain
23	chr13:67672600-67674800	Weak transcription	Brain Angular Gyrus	brain
24	chr13:67672800-67676400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr13:67673000-67674400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr13:67673000-67675800	Enhancers	Brain Cingulate Gyrus	brain
27	chr13:67673200-67676000	Enhancers	Brain Hippocampus Middle	brain
28	chr13:67673400-67674600	Weak transcription	Brain Anterior Caudate	brain
29	chr13:67673600-67674000	Enhancers	Placenta Amnion	Placenta Amnion
30	chr13:67673600-67675600	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr13:67673800-67674200	Flanking Active TSS	Hela-S3	cervix
32	chr13:67674000-67676400	Weak transcription	Placenta Amnion	Placenta Amnion
33	chr13:67674200-67674600	Active TSS	Hela-S3	cervix
34	chr13:67674200-67676000	Enhancers	HSMM	muscle
35	chr13:67674400-67675000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr13:67674400-67676000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr13:67674600-67674800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr13:67674600-67675000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr13:67674600-67675200	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr13:67674600-67675200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr13:67674600-67675400	Flanking Active TSS	Hela-S3	cervix
42	chr13:67674600-67675600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr13:67674600-67676000	Enhancers	Brain Anterior Caudate	brain
44	chr13:67674600-67676200	Enhancers	Brain Inferior Temporal Lobe	brain
45	chr13:67674600-67676400	Enhancers	Muscle Satellite Cultured Cells	--
46	chr13:67674800-67675000	Enhancers	Rectal Smooth Muscle	rectum
47	chr13:67674800-67675200	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr13:67674800-67675200	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr13:67674800-67675200	Enhancers	NHEK	skin
50	chr13:67674800-67676000	Enhancers	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links